Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.63 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.63 |
| ▸ | ATM | Q13315 | 1/20 | 0.63 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | RECQL | P46063 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | PRKCA | P17252 | 1/20 | 0.41 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.41 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.41 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.41 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.39 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.39 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3740920 | 0.91 | TSHR (0.62) | TSHRCYP3A4ATMTDP1ALDH1A1 | |
| SCHEMBL27493864 | 0.90 | TSHR (0.68) | TSHRCYP3A4ATMTDP1ALDH1A1 | |
| SCHEMBL29104733 | 0.90 | TSHR (0.58) | TSHRCYP3A4ATMTDP1ALDH1A1 | |
| SCHEMBL420275 | 0.86 | CYP3A4 (0.75) | TSHRCYP3A4ATMTDP1ALDH1A1 | |
| SCHEMBL3740929 | 0.86 | TSHR (0.69) | TSHRCYP3A4ATMTDP1ALDH1A1 | |
| SCHEMBL246876 | 0.86 | CYP3A4 (0.86) | TSHRCYP3A4ATMTDP1ALDH1A1 | |
| SCHEMBL2344891 | 0.85 | CYP3A4 (0.79) | TSHRCYP3A4ATMTDP1ALDH1A1 | |
| SCHEMBL31486463 | 0.85 | TSHR (0.77) | TSHRCYP3A4ATMTDP1ALDH1A1 | |
| SCHEMBL418613 | 0.84 | CYP3A4 (0.72) | TSHRCYP3A4ATMTDP1ALDH1A1 | |
| SCHEMBL3756074 | 0.84 | TSHR (0.61) | TSHRCYP3A4ATMTDP1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1893910-A | Cyclic siloxane compositions for active ingredient release | GEN ELECTRIC (US) | 2007-01-10 | — | — | CN | claimed |
| US-11066351-B2 | Organic compound, three-dimensional organic framework formed by using organic compound, separation sieve and optical layer, which comprise organic framework, and optical device comprising optical layer as optical amplification layer | IUCF-HYU (INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY) (KR) | 2021-07-20 | — | — | US | disclosed |
| CN-109071693-B | Resin composition for forming high refractive index cured film | 日产化学株式会社 | 2021-05-11 | — | — | CN | disclosed |
| EP-3109914-B1 | CHARGE-TRANSPORTING VARNISH | NISSAN CHEMICAL CORP (JP) | 2021-04-28 | — | — | EP | disclosed |
| EP-3252840-B1 | VARNISH FOR FORMATION OF CHARGE-TRANSPORTING THIN FILM | NISSAN CHEMICAL CORP (JP) | 2020-03-11 | — | — | EP | disclosed |
| EP-3249710-B1 | CHARGE-TRANSPORTING VARNISH, CHARGE-TRANSPORTING FILM, AND ORGANIC ELECTROLUMINESCENT ELEMENT | NISSAN CHEMICAL CORP (JP) | 2019-11-13 | — | — | EP | disclosed |
| US-10301484-B2 | Varnish for formation of charge-transporting thin film | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2019-05-28 | — | — | US | disclosed |
| US-20190031586-A1 | ORGANIC COMPOUND, THREE-DIMENSIONAL ORGANIC FRAMEWORK FORMED BY USING ORGANIC COMPOUND, SEPARATION SIEVE AND OPTICAL LAYER, WHICH COMPRISE ORGANIC FRAMEWORK, AND OPTICAL DEVICE COMPRISING OPTICAL LAYER AS OPTICAL AMPLIFICATION LAYER | INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY (KR) | 2019-01-31 | — | — | US | disclosed |
| US-20180002539-A1 | VARNISH FOR FORMATION OF CHARGE-TRANSPORTING THIN FILM | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2018-01-04 | — | — | US | disclosed |
| EP-3252840-A1 | VARNISH FOR FORMATION OF CHARGE-TRANSPORTING THIN FILM | Nissan Chemical Industries, Ltd. (JP) | 2017-12-06 | — | — | EP | disclosed |
| EP-3249710-A1 | CHARGE-TRANSPORTING VARNISH, CHARGE-TRANSPORTING FILM, AND ORGANIC ELECTROLUMINESCENT ELEMENT | Nissan Chemical Industries, Ltd. (JP) | 2017-11-29 | — | — | EP | disclosed |
| WO-2017141049-A1 | METHYLAMINE DERIVATIVES AS LYSYSL OXIDASE INHIBITORS FOR THE TREATMENT OF CANCER | THE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL (GB) | 2017-08-24 | — | — | WO | disclosed |
| EP-3109914-A1 | CHARGE-TRANSPORTING VARNISH | Nissan Chemical Industries, Ltd. (JP) | 2016-12-28 | — | — | EP | disclosed |
| EP-0953560-B1 | Method, catalyst and apparatus for producing acetaldehyde from acetic acid | EASTMAN CHEM CO (US) | 2004-05-26 | — | — | EP | disclosed |
| US-6121498-A | HYDROGENATING ACETIC ACID USING IRON OXIDE CATALYST THAT CONTAINS PALLADIUM, ABSORBING ACETALDEHYDE FROM GASEOUS PRODUCT USING SOLVENT CONTAINING ACETIC ACID | EASTMAN CHEMICAL COMPANY (US) | 2000-09-19 | — | — | US | disclosed |
| US-6114475-A | PROVIDING COMPOUND IN SOLID, LIQUID, OR GASEOUS FORM CAPABLE OF REDUCING THE BOILING POINT OF WATER BY AT LEAST ABOUT 2 DEGREES C, VAPORIZING COMPOUND, PASSING COMPOUND IN GASEOUS FORM INTO COOL REGIONS OF THE SYSTEM TO MIX WITH WATER | UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) | 2000-09-05 | — | — | US | disclosed |
| EP-0953560-A1 | Method, catalyst and apparatus for producing acetaldehyde from acetic acid | EASTMAN CHEMICAL COMPANY (US) | 1999-11-03 | — | — | EP | disclosed |
| EP-0813590-A1 | CLEANING PROCESS AND APPARATUS | THE DOW CHEMICAL COMPANY (US) | 1997-12-29 | — | — | EP | disclosed |
| WO-1996028535-A1 | CLEANING PROCESS AND APPARATUS | THE DOW CHEMICAL COMPANY (US) | 1996-09-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11066351-B2 | Organic compound, three-dimensional organic framework formed by using organic compound, separation sieve and optical layer, which comprise organic framework, and optical device comprising optical layer as optical amplification layer | OR10J3, POF1B, ORC3 | TSHR 4643/4885CYP3A4 376/4885ATM 1799/4885 |
| US-20190031586-A1 | ORGANIC COMPOUND, THREE-DIMENSIONAL ORGANIC FRAMEWORK FORMED BY USING ORGANIC COMPOUND, SEPARATION SIEVE AND OPTICAL LAYER, WHICH COMPRISE ORGANIC FRAMEWORK, AND OPTICAL DEVICE COMPRISING OPTICAL LAYER AS OPTICAL AMPLIFICATION LAYER | OR10J3, POF1B, ORC3 | TSHR 4643/4885CYP3A4 376/4885ATM 1799/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.